Most of them were diagnosed at an early stage with ER-positive, PR-positive, or HER2-negative tumors and received surgery, while only less than half of them received radiation (43.6%) and chemotherapy (44.1%) for breast cancer. The gene discussed is PGR; the disease is breast carcinoma.